Summary The association between coffee consumption and the incidence rate of breast cancer has been analysed in 152 incident cases of breast cancer that developed among 14,593 Norwegian women during a mean follow-up of 12 years. At the time of inquiry they were between 35 and 51 years of age, and at the end of follow-up between 46 and 63. There was an overall weak negative association between daily intake of coffee and risk of breast cancer, which was not statistically significant. However, the association with coffee varied, depending on the body mass index (BMI) of the women. In the lean (Quetelet<24; population mean) there was an inverse relation between coffee intake and risk of breast cancer (X2 trend = 5.07, P = 0.02). In this group, women who reported drinking 5 cups or more per day had an age-adjusted IRR of 0.5 (95% confidence intervals, 0.3 and 0.9) compared to women who had 2 cups or less. In women with Quetelet's index equal to or greater than 24 there was a positive relation between coffee intake and breast cancer risk (X2 trend = 2.33, P = 0.13), where the corresponding age-adjusted IRR was 2.1 (95% confidence intervals, 0.8 and 5.2). This interaction effect between coffee intake and BMI was statistically significant (X2 interaction = 10.2, 3 d.f., P = 0.02). In summary, the results of this study suggest that coffee consumption reduces the risk of breast cancer in lean women, whereas coffee might have the opposite effect in relatively obese women.
The hypothesis that coffee consumption may be associated with the risk of breast cancer has been related to the methylxanthines (caffeine, theophylline, and theobromine) contained in coffee (Rohan & Bain, 1987) . Among seven case-control studies, six have found a positive, but not statistically significant association with coffee drinking (Lubin et al., 1981; Lawson et al., 1981; Mansel et al., 1982; Rosenberg et al., 1985; La Vecchia et al., 1986; Rohan & McMichael, 1988) . The remaining study displayed a statistically significant negative association (Lubin et al., 1985) . Two prospective studies have detected weak negative associations between coffee consumption and breast cancer risk, both of which were not statistically significant (Snowdon & Phillips, 1984; Jacobsen et al., 1986) . There is no clear experimental evidence suggesting that coffee is related to mammary carcinogenesis. In fact, the available information shows contradicting effects of coffee (Minton et al., 1983; Rothwell, 1974) .
In this prospective study of 14,593 Norwegian women we provide epidemiological evidence that coffee consumption may be related to the risk of breast cancer.
Methods
Between 1974 and 1977 all women 35-49 years of age who were living in three separate counties in Norway were invited to participate in a health screening examination organised by the National Health Screening Service (Bjartveit et al., 1979 (Bjartveit et al., , 1983 The food frequency questionnaire has been described elsewhere (Solvoll et al., 1989) , but the main question related to coffee consumption was phrased to obtain information on the number of cups of coffee one would usually drink per day, and the respondents could select among six fixed alternative categories. Information on coffee has been compared to data from a 24-hour recall among a subsample of the participants (Solvoll, 1983) , and it was concluded that the questionnaire produced fairly reliable information on intake of items that were consumed on a regular, daily basis (e.g. coffee consumption).
Body mass index (BMI) was computed as the measured weight (in kg) divided by the squared value of the measured height (in metres) to provide Quetelet's index. Total serum cholesterol was measured at the central laboratory (Bjartveit et al., 1979 (Bjartveit et al., , 1983 , according to the method used in the Lipid Research Clinics Program, and information on cigarette smoking was obtained from the primary questionnaire.
In the analysis, coffee consumption has been divided into four categories. Very few women abstained from coffee, and abstainers and low consumers (1-2 cups per day) were therefore included in the lowest (reference) category of intake. For each person belonging to a certain frequency category, observation years at risk of developing breast cancer were computed as the number of years accumulated years or later were computed from the time a person reached age 51 and until withdrawal. This procedure allowed comparison of person-time based incidence rates of breast cancer for each category of daily coffee consumption, yielding overall estimates, and distinguishing diagnosis made before and after the age of 51, roughly approximating pre-and postmenopausal breast cancer incidence.
Incidence rate ratios (IRR) were computed as the rate in a specific category of coffee intake divided by the estimated rate in the reference group of lowest intake. The precision of the IRR estimates was assessed by 95% confidence intervals (CI) using Mietinnen's test-based method applying Mantel--Haenszel X2 statistics (Kleinbaum et al., 1982) . The effect of age was adjusted using the direct method for five-year age categories of person years. Adjustment for other covariables and tests for linear trend followed the Mantel-Haenszel methods (Rothman, 1986) . Testing for interaction was performed by fitting the (cumulative incidence) data to multiple logistic models, comparing the maximum likelihood statistics of a model which contained a product between body mass index (two categories) and coffee consumption (four categories) to a model where this term was omitted.
Results
We first examined the relation of daily coffee consumption with age, body height, body mass index (BMI), total serum cholesterol, and cigarette smoking (Table I) , to evaluate whether any one of these factors might distort the association between coffee intake and risk of breast cancer. There was no difference in coffee consumption between age groups, and after adjustment for age there was no relation between coffee intake and body height. We found a weak tendency for more obese women to drink more coffee, and there was a stronger association between total serum cholesterol and coffee consumption, as there was a tendency for women who smoked 10 or more cigarettes per day to report higher intakes of coffee per day than nonsmoking women.
In this cohort, women who were 163 cm (population median) or taller had an increased risk of breast cancer (ageadjusted IRR = 1.5, P = 0.02), and relative overweight was inversely related to breast cancer risk. Thus, the age-adjusted IRR of women whose Quetelet's index was 24 (population median) and above was 0.7 (P = 0.03) compared to women with Quetelet lower than 24. There was a weak, but not statistically significant negative association between total serum cholesterol and risk of breast cancer. Women whose cholesterol was equal to or above the population median (6.6 mmol 1') had an age-adjusted IRR of 0.8 (P = 0.20). There was no difference in risk between women who smoked 10 or more cigarettes per day and nonsmoking women (ageadjusted IRR = 1.1, P= 0.67).
We observed an overall weak, but not statistically significant inverse relation between coffee consumption and risk of breast cancer, which was confined to an effect in women who were diagnosed with disease before the age of 51 (Table II) . To explore whether this might be an effect of truly premenopausal cancer, only cases diagnosed at age 47 or younger were examined (data not shown), but this did not materially alter the negative association.
Body mass index was inversely related to breast cancer risk, and simultaneously positively associated with coffee consumption. We therefore examined the relation between daily coffee intake and breast cancer risk for lean (Quetelet < 24) and more obese (Quetelet > 24) women separately (Table III Previous studies have displayed contradicting relations between coffee consumption and breast cancer. However, one large case-control study (Lubin et al., 1985) found a negative association, and two prospective studies (Snowdon & Philips, 1984; Jacobsen et al., 1986 ) also reported inverse effects of coffee, but these were not statistically significant. No study that we are aware of has made a distinction between coffee effects among lean and more obese women. Approximately 95% of the participating women returned the dietary questionnaire. Although the remaining 5% may represent a selected part of the population with respect to coffee consumption, it seems unlikely that these would materially affect the associations detected with breast cancer. Coffee intake was reliably measured (Solvoll, 1983 (Solvoll, , 1989 and showed that consumption was generally high, with a population mean of 3.5 cups per day, and that very few women abstained from coffee. Despite a low number of abstainers, there was sufficient variation in consumption to construct 4 separate categories of intake. The 24-hour recall indicated that the accuracy of reporting was fairly high. Although some misclassification could not have been avoided, this would probably be non-differential and not associated with future risk of developing breast cancer. If anything, this suggests that misclassification would produce results that are an underestimate of the real effects of coffee.
A limitation of this study is the lack of information on factors that are known to affect the risk of breast cancer. Apart from being independent risk factors for the disease in the absence of the exposure under study, potentially confounding variables should be associated with the exposure (Rothman, 1986) . Consequently, intake of coffee should be associated with variables like age at menarche and age at first full term pregnancy for confounding from these factors to be anticipated in the data. We attempted to make an adjustment for reproductive history by controlling for the effect of occupational status (housewife/not housewife), but this did not materially alter the observed relation with coffee consumption.
There are indications that among premenopausal women those who are lean are at increased risk of developing breast cancer compared to women who are more obese (Willett et al., 1985) . In this study the oldest participant was still only 63 years at the end of follow-up. This indicates that a majority of the cases were premenopausal at the onset of disease, and most certainly were premenopausal at initiation and during the preclinical induction phase of disease. Since the protective effect of obesity on the risk of breast cancer appears to be restricted to premenopausal women, this may indicate that there exists a crucial relationship between body mass and ovarian activity. Then the results of this study might suggest that some component contained in coffee (possibly methylxanthines) could have a role to play in this relationship. Whereas large daily doses of coffee may favourably affect the risk of developing breast cancer in lean women, more obese women might achieve a benefit from restricting their daily coffee intake.
